RutikaMehtaMD

PubMed

• A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.
  Jasra, S., Opyrchal, M., Norton, L., Mehta, R.> ;Clinical breast cancer. 2016 Sep 26
• Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center.
  Miller K, Mehta R, Abraham J, Opneja A, Jain RK> ;Am. J. Clin. Oncol.. 2015-10-15
• Cancer Survivorship and Models of Survivorship Care: A Review.
  Miller, K. D.,Pandey, M.,Jain, R.,Mehta, R.> ;Am. J. Clin. Oncol.. 2015 Jan 31
• Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer.
  Yesim Gökmen-Polar, Chirayu P. Goswami, Rachel A. Toroni, Kerry L. Sanders, Rutika Mehta, Usha Sirimalle, Bogdan Tanasa, Changyu Shen, Lang Li, Mircea Ivan, Sunil Badv...> ;Journal of Cancer. 2014 Aug 15
• 4 citations
  Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models.
  Gökmen-Polar, Y., Liu, Y., Toroni, R. A., Sanders, K. L., Mehta, R., Badve, S., Rommel, C., Sledge, G. W.> ;Breast cancer research and treatment. 2012 Oct 23
• 3 citations
  Extrathoracic metastases of thymic origin: a review of 35 cases.
  Tudor Vladislav, Rohit K. Jain, Rudy Alvarez, Rutika Mehta, Yesim Gökmen-Polar, Kenneth A. Kesler, John D. Henley, Patrick J. Loehrer, Sunil Badve> ;Modern Pathology. 2012 Mar 1
• 1 citation
  PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.
  Johnson, E. O., Chang, K., de Pablo, Y., Ghosh, S., Mehta, R., Badve, S., Shah, K.> ;Journal of cell science. 2011 Aug 3
• Atypical ductal hyperplasia: interobserver and intraobserver variability.
  Jain RK, Mehta R, Dimitrov R, Larsson LG, Musto PM, Hodges KB, Ulbright TM, Hattab EM, Agaram N, Idrees MT, Badve S> ;Mod. Pathol.. 2011-07-01
• 41 citations
  FOXA1 is an independent prognostic marker for ER-positive breast cancer.
  Mehta, R. J., Jain, R. K., Leung, S., Choo, J. R., Nielsen, T. O., Huntsman, D., Nakshatri, H., Badve, S.> ;Breast cancer research and treatment. 2011 Apr 20
• High-level expression of forkhead-box protein A1 in metastatic prostate cancer.
  Rohit K. Jain, Rutika Mehta, Harikrishna Nakshatri, Muhammad T. Idrees, Sunil Badve> ;Histopathology. 2011 Apr 1
• 21 citations
  Personalized medicine: the road ahead.
  Mehta, R., Jain, R. K., Badve, S.> ;Clinical breast cancer. 2011 Mar 23
• 3 citations
  Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
  Patel, J. B., Appaiah, H. N., Burnett, R. M., Bhat-Nakshatri, P., Wang, G., Mehta, R., Badve, S., Thomson, M. J., Hammond, S., Steeg, P., Liu, Y., Nakshatri, H.> ;Oncogene. 2010 Nov 9
• Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: Insights from PyMT transgenic mouse model
  Kasi McCune, Rutika Mehta, Mangesh A. Thorat, Sunil Badve, Harikrishna Nakshatri> ;Oncology Reports. 2010 Nov 1
• ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
  Hitesh Nidumanda Appaiah, Poornima Bhat-Nakshatri, Rutika Mehta, Mangesh A. Thorat, Sunil Badve, Harikrishna Nakshatri> ;Cancer Biology & Therapy. 2010 Sep 15
• 1 citation
  WHO types A and AB thymomas: not always benign.
  Jain, R. K., Mehta, R. J., Henley, J. D., Kesler, K. A., Loehrer, P. J., Badve, S.> ;Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2010 Sep 14
• Expression of high-molecular-weight cytokeratin (34βE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast
  Rutika Mehta, Rohit K. Jain, Nour Sneige, Sunil Badve, Erika Resetkova> ;Journal of Clinical Pathology. 2010 Aug 1
• 7 citations
  Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
  Erika Resetkova, Jorge S. Reis-Filho, Rohit K. Jain, Rutika Mehta, Mangesh A. Thorat, Harikrishna Nakshatri, Sunil Badve> ;Breast Cancer Research and Treatment. 2010 Aug 1
• Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.
  Geyer, F. C., Lambros, M. B., Natrajan, R., Mehta, R., Mackay, A., Savage, K., Parry, S., Ashworth, A., Badve, S., Reis-Filho, J. S.> ;Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2010 May 11
• 1 citation
  Conjunctival squamous cell carcinoma due to ocular prostheses: a case report and review of literature.
  Jain, R. K., Mehta, R., Badve, S.> ;Pathology oncology research : POR. 2010 Apr 9
• 2 citations
  Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes.
  Gökmen-Polar, Y., Mehta, R., Tuzmen, S., Mousses, S., Thorat, M. A., Sanders, K. L., Turbin, D., Leung, S., Huntsman, D. G., Sledge, G. W., Badve, S.> ;Breast cancer research and treatment. 2010 Jan 26
• Mucosal expression of cyclooxygenase isoforms 1 and 2 is increased with worsening damage to the gastric mucosa.
  Bhandari P, Bateman AC, Mehta RL, Patel P> ;Histopathology. 2005-03-01
• Join now to see all

Lectures

• A phase II study of TAS-102 in combination with ramucirumab in advanced, refractory gastric or gastroesophageal junction (GEJ) adenocarcinoma. 
  2019 ASCO Annual Meeting - 6/1/2019